Plasma levels of heat shock protein 70 in patients with prostate cancer: A potential biomarker for prostate cancer

Clinical Prostate Cancer

Volumn 3, Issue 1, 2004, Pages 49-53

  Abe, Miyako ^a   Manola, Judith B ^a   Oh, William K ^a   Parslow, Diane L ^a   George, Daniel J ^a   Austin, Carolyn L ^a   Kantoff, Philip W ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Early stage prostate cancer; Metastasis; Prostate specific antigen

Indexed keywords

HEAT SHOCK PROTEIN 70; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SCREENING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; HUMAN; MALE; NORMAL VALUE; PROSTATE CANCER; PROTEIN BLOOD LEVEL;

EID: 3442878404     PISSN: 15400352     EISSN: None     Source Type: Journal    
DOI: 10.3816/CGC.2004.n.013     Document Type: Article

References (19)

1. Lindquist S, Craig FA. The heat-shock proteins. Annu Rev Genet 1988; 22:631-677.
2. Jäätrelä M. Minireview - Escaping cell death: Survival proteins in cancer. Exp Cell Res 1999; 248:30-43.
3. Suzuki K, Kodama S, Watanabe M. Effect of low-dose preirradiation on induction of the HSP70B-LacZ fusion gene in human cells treated with heat shock. Radiat Res 1998; 149:195-201.
4. Kang CM, Park KP, Cho CK, et al. Hspa4 (HSP70) is involved in the radioadaptive response: Results from mouse splenocytes. Radiat Res 2002; 157:650-655.
5. Jäättelä M. Over-expression of hsp70 confers tumorigenicity to mouse fibrosarcoma cells. Int J Cancer 1995; 60:689-693.
6. Seo JS, Park YM, Kim JI, et al. T cell lymphoma in transgenic mice expressing the human hsp70 gene. Biochem Biophys Res Commun 1996; 218:582-587.
7. Alaiya AA, Oppermann M, Langridge J, et al. Identification of proteins in human prostate tumor material by two-dimensional gel electrophoresis and mass spectrometry. Cell Mol Life Sci 2001; 58:307-311.
8. Walsh RC, Koukoulas I, Garnham A, et al. Exercise increases serum Hsp72 in humans. Cell Stress Chaperones 2001; 6:386-393.
9. Dybdahl B, Wahba A, Lien E, et al. Inflammatory response after open heart surgery: Release of heat-shock protein70 and signaling through toll-like receptor-4. Circulation 2002; 105:685-690.
10. Wright BH, Cotton JM, El-Nahas AM, et al. Elevated levels of circulating heat shock protein 70 (Hsp70) in peripheral and renal vascular disease. Heart Vessels 2000; 15:18-22.
11. Pockley AG, de Faire U, Kiessling R, et al. Circulating heat shock protein and heat shock protein antibody levels in established hypertension. J Hypertens 2002; 20:1815-1820.
12. Lieberfarb ME, Schultz D, Whittington R, et al. Using PSA, biopsy Gleason score, clinical stage, and the percentage of positive biopsies to identify optimal candidates for prostate-only radiation therapy. Int J Radiat Oncol Biol Phys 2002; 53:898-903.
13. Wilcoxon F. Individual comparisons by ranking methods. Biometrics 1945; 1:80-83.
14. Breiman L, Friedman JH, Olshen RA, et al. Classification and regression trees. Belmont, CA: Wadsworth International Group; 1984.
15. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 1988; 44:837-845.
16. Balk SP, Ko YJ, Bubley GJ. Biology of prostate-specific antigen. J Clin Oncol 2003; 21:383-391.
17. Kirby RS, Christmas TJ, Brawer M. Prostate Cancer. Wilmington, DE: ZENECA Pharmaceuticals; 1996.
18. Guzhova I, Kislyakova K, Moskaliova O, et al. In vitro studies show that Hsp70 can be released by glia and that exogenous Hsp70 can enhance neuronal stress tolerance. Brain Res 2001; 914:66-73.
19. Punglia RS, D'Amico AV, Catalona WJ, et al. Effect of verification bias on screening for prostate cancer by measurement of pros rate-specific antigen. N Engl J Med 2003; 349:335-342.